Brain monoamines in human cerebral infarcts. A preliminary study

Area of Science:

• Neuroscience
• Biochemistry
• Neuropathology

Background:

• Cerebral infarction, a major cause of neurological disability, involves complex pathophysiological changes.
• Monoamines, including dopamine (DA) and serotonin (5-HT), play critical roles in brain function and are implicated in neurological disorders.

Purpose of the Study:

• To investigate the impact of acute and old cerebral infarction on brain monoamine levels (DA, 5-HT) and their metabolite (5-hydroxyindole acetic acid, 5-HIAA).
• To explore the relationship between monoamine metabolism disorders and the development of postischemic brain damage and cerebral edema.

Main Methods:

• Spectrofluorometric assay of dopamine (DA), serotonin (5-HT), and 5-hydroxyindole acetic acid (5-HIAA) in various brain regions.
• Analysis was performed on brain tissue from 8 human patients who experienced acute or old cerebral infarction.

Main Results:

• Total depletion of DA and 5-HT was observed in both recent and old infarcts, with slight reductions in remote nonischemic areas.
• 5-HIAA was significantly reduced in acute ischemic necrosis.
• The perifocal edema zone showed accumulation of 5-HT and 5-HIAA, while the degradation zone of old infarcts showed a mild decrease, suggesting normalization of metabolism.

Conclusions:

• Disruptions in brain monoamine metabolism are associated with cerebral infarction.
• These findings support the hypothesis that monoamine metabolism disorders contribute to postischemic brain damage and associated cerebral edema.